Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial.
Saved in:
| Title: | Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial. |
|---|---|
| Authors: | Yamanaka T; Kanagawa Cancer Center, Yokohama, Japan., Sohn J; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Sudo K; National Cancer Center Hospital, Tokyo, Japan., Mukai H; National Cancer Center Hospital East, Kashiwa, Japan., Yamamoto N; Chiba Cancer Center, Chiba, Japan., Chung CF; Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan., Lu YS; National Taiwan University Hospital, Taipei, Taiwan., Lee KH; Seoul National University Hospital, Seoul, Republic of Korea., Lee SC; National University Cancer Institute Singapore, Singapore, Singapore., Iwasa T; Faculty of Medicine, Kindai University, Sakai, Japan., Iwata H; Aichi Cancer Center Hospital, Nagoya, Japan., Watanabe K; National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan., Jung KH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Tanabe Y; Toranomon Hospital, Tokyo, Japan., Kang SY; Ajou University School of Medicine, Suwon, Republic of Korea., Yasojima H; National Hospital Organization Osaka National Hospital, Osaka, Japan., Aogi K; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Tokunaga E; National Hospital Organization Kyusyu Cancer Center, Fukuoka, Japan., Sim SH; National Cancer Center, Goyang-si, Republic of Korea., Yap YS; National Cancer Centre Singapore, Singapore, Singapore., Matsumoto K; Hyogo Cancer Center, Akashi, Japan., Tseng LM; Taipei Veterans General Hospital, Taipei, Taiwan., Umeyama Y; Pfizer R&D Japan, Tokyo, Japan., Noguchi E; National Cancer Center Hospital, Tokyo, Japan., Hata T; National Cancer Center Hospital, Tokyo, Japan., Kuchiba A; National Cancer Center Hospital, Tokyo, Japan., Shibata T; National Cancer Center Hospital, Tokyo, Japan., Nakamura K; National Cancer Center Hospital, Tokyo, Japan., Fujiwara Y; National Cancer Center Hospital, Tokyo, Japan., Tamura K; National Cancer Center Hospital, Tokyo, Japan., Yonemori K; National Cancer Center Hospital, Tokyo, Japan. kyonemor@ncc.go.jp. |
| Source: | Breast cancer (Tokyo, Japan) [Breast Cancer] 2026 Jun 24. Date of Electronic Publication: 2026 Jun 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
